Proteins.1

Proteins.1, an Espoo-based deep-tech diagnostics startup, has raised $4.7 million in pre-seed funding led by Lifeline Ventures and Cloudberry Ventures, with participation from VTT and Business Finland. The company is developing a patented single-molecule protein amplification platform to enable ultra-sensitive disease detection, addressing the challenge that proteins cannot be amplified like DNA. The funding will support the expansion and development of its technology aimed at earlier disease detection at the molecular level.